Johnson & Johnson says a second dose greatly enhances protection against COVID-19

Johnson & Johnson said persons who received a second dose of its COVID-19 vaccine enjoyed 94% protection against symptomatic disease, an increase from 74% under a one-shot regimen and a level on par with early studies of two-dose vaccines from Pfizer-BioNTech and Moderna. The New Jersey-based company said people who ...

Google, News